Gastroesophageal reflux disease and temporomandibular disorder risk: a nationwide cohort study
Abstract
Background: Gastroesophageal reflux disease (GERD) and temporomandibular disorders (TMDs) are multifactorial conditions characterized by complex interactions among biological, psychological, and behavioral factors. GERD is increasingly recognized as a systemic disorder with multiple extra esophageal manifestations, while TMD represents a major source of chronic orofacial pain worldwide. This study aims to examine the association between GERD and TMD risk in a large-scale, population-based cohort.
Methods: This nationwide cohort study used data from the Korean National Health Insurance Service. We included 195,533 adults aged ≥ 19 years who completed health screenings between 2010 and 2011. GERD was identified using diagnostic codes and two or more prescriptions of acid-suppressive medications for ≥ 2 weeks. Participants with prior TMD, bruxism, dental trauma, malignancy, or reflux-inducing medications were excluded. A 1:3 propensity score matching was performed to reduce confounding. The primary outcome was the incidence of TMD. Multivariable Cox regression models were used to estimate adjusted hazard ratios with a 95% confidence interval.
Results: After matching, 40,755 individuals with GERD and 115,242 controls were included. The incidence of TMD was higher in the GERD group than in the control group (6.65 vs. 4.31 per 1,000 person-years). GERD was associated with an increased risk of TMD, with an adjusted hazard ratio of 1.23 and a 95% confidence interval of 1.15-1.31.…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 195,533 participants or records.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.